Vertical Pathway Inhibition of Receptor Tyrosine Kinases and BAD with Synergistic Efficacy in Triple Negative Breast Cancer

NCK promoted apoptosis and G0/G1 cell cycle arrest of TNBC cell lines in vitro, concordant with gene expression analyses, and reduced in vivo xenograft growth and metastatic burden, demonstrating efficacy as a single agent.